Morgan Stanley’s Lexaria Bioscience LEXX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-20,229
| Closed | -$42.5K | – | 8167 |
|
|
2024
Q4 | $42.5K | Sell |
20,229
-2,753
| -12% | -$5.78K | ﹤0.01% | 6341 |
|
|
2024
Q3 | $70.1K | Hold |
22,982
| – | – | ﹤0.01% | 6122 |
|
|
2024
Q2 | $63.9K | Sell |
22,982
-372
| -2% | -$1.03K | ﹤0.01% | 6103 |
|
|
2024
Q1 | $84.8K | Buy |
+23,354
| New | +$84.8K | ﹤0.01% | 6056 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | – | – | 8044 |
|
|
2021
Q4 | $0 | Sell |
1
-999
| -100% | – | ﹤0.01% | 8042 |
|
|
2021
Q3 | $6K | Buy |
+1,000
| New | +$6K | ﹤0.01% | 7450 |
|